DaVita Inc
Company Profile
Business description
DaVita is the largest provider of dialysis services in the United States, boasting market share that eclipses 35% when measured by both patients and clinics. The firm operates over 3,000 facilities worldwide, mostly in the us, and treats about 250,000 patients globally each year. Government payers dominate us dialysis reimbursement. DaVita receives about two thirds of us sales at government (primarily Medicare) reimbursement rates, with the remainder coming from commercial insurers. While commercial insurers represent only about 10% of the us patients treated, they represent nearly all of the profits generated by DaVita in the us dialysis business.
Contact
2000 16th Street
DenverCO80202
USAT: +1 720 631-2100
Sector
Healthcare
Stock type
Defensive
Industry
Medical Care Facilities
Fiscal Year End
31 December 2024
Employees
70,000
DaVita Inc News & Analysis
stocks
3 bargains in Buffett's stock list
stocks
6 healthcare buys spanning Australia, US
stocks
7 defensive stocks on sale
Morningstar Investment Ideas
Markets
Index | Last price | Change | % Change |
|---|---|---|---|
| All Ordinaries | 8,450.90 | 64.30 | -0.76% |
| CAC 40 | 7,234.57 | 7.59 | 0.11% |
| DAX 40 | 19,068.46 | 34.82 | 0.18% |
| Dow JONES (US) | 43,910.98 | 382.15 | -0.86% |
| FTSE 100 | 8,037.53 | 11.76 | 0.15% |
| HKSE | 19,823.45 | 23.43 | -0.12% |
| NASDAQ | 19,281.40 | 17.36 | -0.09% |
| Nikkei 225 | 38,721.66 | 654.43 | -1.66% |
| NZX 50 Index | 12,674.49 | 74.87 | -0.59% |
| S&P 500 | 5,983.99 | 17.36 | -0.29% |
| S&P/ASX 200 | 8,193.40 | 62.20 | -0.75% |
| SSE Composite Index | 3,439.28 | 17.31 | 0.51% |